Home › Biochemistry › Immunodeficiencies Associated with Nucleotide Metabolism

Immunodeficiencies Associated with Nucleotide Metabolism

Q: Which specific kinases phosphorylate uncleaved deoxyadenosine to dATP?

Literature specifically highlights deoxycytidine kinase: it exhibits broad substrate specificity and phosphorylates not only deoxycytidine, but also deoxyguanosine and deoxyadenosine. Additionally, sources note that excess deoxyadenosine is phosphorylated by kinases to form dATP, though other specific kinases mediating this conversion are not individually named.

For medical students2 min readUpdated 2026-10-10

Immunodeficiencies associated with nucleotide metabolism arise from genetic defects in enzymes responsible for purine degradation. This leads to the intracellular accumulation of toxic intermediate metabolites that completely block DNA synthesis, halting the division of immune system cells.

Primary CauseDisruption of purine nucleotide catabolism

Key TargetRibonucleotide reductase, responsible for deoxynucleotide synthesis

Toxic AgentsExcess dATP and dGTP inside rapidly dividing cells

Outcome Without TreatmentSevere chronic infections and early patient mortality

General Pathogenesis: How Purines Disrupt Immunity

Normally, purine nucleosides are progressively degraded down to end products, specifically nitrogenous bases and uric acid. When specific catabolic enzymes are genetically deficient, this process slows down dramatically.

The biochemical cascade unfolds as follows:

Due to the blockade of salvage and degradation pathways, huge amounts of ribonucleotides and deoxyribonucleotides accumulate within cells.
In tissues with high mitotic activity (such as lymphocytes), the concentrations of dATP and dGTP reach critical levels.
Excess amounts of these substances act as powerful allosteric inhibitors of the enzyme ribonucleotide reductase (RNR).
Normally, RNR catalyzes the conversion of ribonucleoside diphosphates (NDPs) to deoxyribonucleotides (dNDPs) using reduced thioredoxin. When the enzyme is blocked, the synthesis of all other dNDPs ceases.
An acute shortage of building blocks for DNA replication occurs. The cell loses its ability to divide, which is most devastating to the lymphocyte population.

Severe Combined Immunodeficiency (SCID)

This condition is caused by a deficiency of the enzyme adenosine deaminase (ADA). This enzyme catalyzes critical deamination reactions:

Adenosine is converted into inosine with the release of ammonia, utilizing water.
Deoxyadenosine undergoes a similar transformation into deoxyinosine.

When ADA fails to function, deoxyadenosine is not degraded; instead, it is phosphorylated by intracellular kinases into dATP (deoxyadenosine triphosphate). Accumulating at massive concentrations, dATP binds to ribonucleotide reductase and completely shuts down the synthesis of all other deoxyribonucleotides (dNTPs).

As a result, the proliferation and maturation of two major immune lineages—T lymphocytes and B lymphocytes—are severely impaired. A profound cellular and humoral immunodeficiency develops. Without timely therapy, infants born with this pathology rapidly succumb to persistent infections.

Purine Nucleoside Phosphorylase Deficiency

A second variant of nucleotide-related immunodeficiency involves a defect in the enzyme purine nucleoside phosphorylase (PNP).

In this case, the biochemical culprit is an excess of dGTP (deoxyguanosine triphosphate), which accumulates in precursor cells. Similar to SCID, dGTP inhibits ribonucleotide reductase, thereby suppressing pyrimidine deoxynucleotide production.

Key features of this disorder:

Unlike the accumulation of dATP, the inhibitory effect of dGTP is significantly weaker.
The pathological process predominantly halts the maturation of T lymphocytes, meaning cellular immunity is primarily compromised in affected patients.
The clinical presentation features frequent, protracted infections that progress to a chronic course.

Mnemonic

SCID (ADA deficiency) hits them all — T and B cells, while PNP deficiency hits only T cells.

Frequently asked questions

What chemical reaction does purine nucleoside phosphorylase normally catalyze?

Normally, purine nucleoside phosphorylase catalyzes the phosphorolytic cleavage of nucleosides, converting them into nitrogenous bases. The reaction is a phosphorolysis of the N-glycosidic bond, releasing ribose-1-phosphate and the free base.

Specific catalyzed transformations include:

Inosine — cleaved to hypoxanthine.
Deoxyinosine — also converted to hypoxanthine.
Guanosine — converted to guanine.

Which specific kinases phosphorylate uncleaved deoxyadenosine to dATP?

Literature specifically highlights deoxycytidine kinase: it exhibits broad substrate specificity and phosphorylates not only deoxycytidine, but also deoxyguanosine and deoxyadenosine.

Additionally, sources note that excess deoxyadenosine is phosphorylated by kinases to form dATP, though other specific kinases mediating this conversion are not individually named.

Why do lymphocytes suffer specifically in these biochemical defects?

Lymphocytes are rapidly dividing cells. Their proliferation and maturation require continuous DNA synthesis, which completely halts when deoxyribonucleotides are deficient.

Which enzyme is inhibited by the accumulation of dATP and dGTP?

Ribonucleotide reductase (RNR)—the key enzyme converting NDPs to dNDPs—is allosterically blocked.

What accumulates during adenosine deaminase deficiency?

Excess uncleaved deoxyadenosine is phosphorylated by kinases, leading to critical intracellular accumulation of dATP.

Go deeper

Mechanism of the ribonucleotide reductase reaction involving reduced thioredoxin
Pathways of deoxyadenosine phosphorylation by cellular kinases
Allosteric regulation of ribonucleotide reductase by various nucleotides
Final stages of purine catabolism and uric acid formation